Debrisoquine metabolism and genetic predisposition to lung cancer
Open Access
- 1 May 1989
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 59 (5) , 686-687
- https://doi.org/10.1038/bjc.1989.142
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquinClinical Pharmacology & Therapeutics, 1985
- Polymorphic drug oxidation in humans.1984
- Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism.BMJ, 1981
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- The metabolism of [14C]‐debrisoquine in man.British Journal of Clinical Pharmacology, 1979
- Polymorphism of carbon oxidation of drugs and clinical implications.BMJ, 1978
- Impairment of drug metabolism in tumor-bearing animalsPublished by Elsevier ,1971